Showing results (1191-1200 of 2,993) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|January 1, 1994
Extravascular proteolysis and the nervous system: serine protease/serpin balanceI V Smirnova, G J Ho, J W Fenton, et al.Seminars in Thrombosis and Hemostasis|March 9, 2002
The coagulation system as a target for the treatment of human gliomasDeborah L Ornstein, Kenneth R Meehan, Leo R ZacharskiSeminars in Thrombosis and Hemostasis|March 9, 2002
Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humansNissi M Varki, Ajit VarkiSeminars in Thrombosis and Hemostasis|May 7, 2002
The role of von Willebrand factor in platelet functionPhilip G de GrootSeminars in Thrombosis and Hemostasis|May 7, 2002
Laboratory diagnosis of congenital von Willebrand diseaseUlrich Budde, Elke Drewke, Kerstin Mainusch, et al.Seminars in Thrombosis and Hemostasis|January 1, 1994
Competitive binding of low molecular mass heparin-tyramine fluorescein-5-isothiocyanate and unlabeled glycosaminoglycans to leukocytesJ Harenberg, R Malsch, L Piazolo, et al.Seminars in Thrombosis and Hemostasis|January 1, 1994
High-performance size exclusion chromatography and polyacrylamide gel electrophoresis for characterization of unfractionated and low molecular mass glycosaminoglycansR Malsch, J HarenbergSeminars in Thrombosis and Hemostasis|July 1, 1976
Plasma inhibitors of the Hageman factor dependent pathwaysA D SchreiberSeminars in Thrombosis and Hemostasis|January 1, 1980
A proposed comprehensive pathophysiology of thrombotic thrombocytopenic purpura with implicit novel tests and therapiesR M Nalbandian, R L HenrySeminars in Thrombosis and Hemostasis|October 1, 1984
Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide AJ Amiral, J M Walenga, J FareedPageof 300